CDKN2A and cancer: Recently, the p16-status has been introduced in the classification algorithm of the 8th edition of the AJCC/UICC cancer staging manual [5, 18] and trials investigated altered therapeutic regimes for “HPV-associated” OPSCCs [17, 34].